DPD status and fluoropyrimidines-based treatment: high activity matters too | BMC Cancer | Full Text

DPD status and fluoropyrimidines-based treatment: high activity matters too | BMC Cancer | Full Text

DPD status and fluoropyrimidines-based treatment: high activity matters too

Dihydropyrimidine dehydrogenase (DPD) status is an indicator of a marked risk for toxicity following fluoropyrimidine (FP)-based chemotherapy. This notion is well-established for low DPD status but little is k...

Authors:Emmanuel Chamorey, Eric Francois, Marie-Christine Etienne, Jean-Marc Ferrero, Frederic Peyrade, Emmanuel Barranger, Alexandre Bozec, Rémy Largillier, Ophelie Cassuto, Julien Viotti, Renaud Schiappa and Gérard Milano

Citation:BMC Cancer 2020 20:436

Content type:Research article

Published on: 18 May 2020

• ViewFull Text
 
• ViewPDF